vs
Franklin BSP Realty Trust, Inc.（FBRT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Franklin BSP Realty Trust, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$81.1M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 22.7%，领先361.4%），Franklin BSP Realty Trust, Inc.同比增速更快（25.8% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 22.6%）
Franklin BSP Realty Trust是一家上市房地产投资信托（REIT），专注于发起、投资和管理商业房地产信贷资产，涵盖优先抵押贷款、夹层融资等相关产品，主要面向美国市场，致力于为投资者创造稳定的经风险调整回报与分红收入。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FBRT vs RIGL — 直观对比
营收规模更大
FBRT
是对方的1.2倍
$69.8M
营收增速更快
FBRT
高出4.6%
21.2%
净利率更高
RIGL
高出361.4%
22.7%
两年增速更快
RIGL
近两年复合增速
22.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.1M | $69.8M |
| 净利润 | $18.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 22.7% | 384.0% |
| 营收同比 | 25.8% | 21.2% |
| 净利润同比 | -39.1% | 1769.2% |
| 每股收益（稀释后） | $0.13 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBRTRIGL
| Q4 25 | $81.1M | $69.8M | ||
| Q3 25 | $89.5M | $69.5M | ||
| Q2 25 | $49.3M | $101.7M | ||
| Q1 25 | $50.1M | $53.3M | ||
| Q4 24 | $64.5M | $57.6M | ||
| Q3 24 | $54.0M | $55.3M | ||
| Q2 24 | $50.9M | $36.8M | ||
| Q1 24 | $54.0M | $29.5M |
净利润FBRTRIGL
| Q4 25 | $18.4M | $268.1M | ||
| Q3 25 | $17.3M | $27.9M | ||
| Q2 25 | $23.2M | $59.6M | ||
| Q1 25 | $24.1M | $11.4M | ||
| Q4 24 | $30.2M | $14.3M | ||
| Q3 24 | $31.6M | $12.4M | ||
| Q2 24 | $-2.2M | $-1.0M | ||
| Q1 24 | $35.9M | $-8.2M |
毛利率FBRTRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率FBRTRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率FBRTRIGL
| Q4 25 | 22.7% | 384.0% | ||
| Q3 25 | 19.3% | 40.2% | ||
| Q2 25 | 47.1% | 58.6% | ||
| Q1 25 | 48.0% | 21.5% | ||
| Q4 24 | 46.8% | 24.9% | ||
| Q3 24 | 58.5% | 22.5% | ||
| Q2 24 | -4.3% | -2.8% | ||
| Q1 24 | 66.6% | -27.9% |
每股收益（稀释后）FBRTRIGL
| Q4 25 | $0.13 | $14.11 | ||
| Q3 25 | $0.12 | $1.46 | ||
| Q2 25 | $0.19 | $3.28 | ||
| Q1 25 | $0.20 | $0.63 | ||
| Q4 24 | $0.28 | $0.82 | ||
| Q3 24 | $0.30 | $0.70 | ||
| Q2 24 | $-0.11 | $-0.06 | ||
| Q1 24 | $0.35 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.3M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.4B | $391.5M |
| 总资产 | $6.1B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FBRTRIGL
| Q4 25 | $167.3M | $155.0M | ||
| Q3 25 | $116.7M | $137.1M | ||
| Q2 25 | $414.1M | $108.4M | ||
| Q1 25 | $215.4M | $77.1M | ||
| Q4 24 | $184.4M | $77.3M | ||
| Q3 24 | $346.2M | $61.1M | ||
| Q2 24 | $94.8M | $49.1M | ||
| Q1 24 | $240.0M | $49.5M |
总债务FBRTRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益FBRTRIGL
| Q4 25 | $1.4B | $391.5M | ||
| Q3 25 | $1.5B | $117.6M | ||
| Q2 25 | $1.5B | $81.9M | ||
| Q1 25 | $1.5B | $18.6M | ||
| Q4 24 | $1.5B | $3.3M | ||
| Q3 24 | $1.5B | $-14.6M | ||
| Q2 24 | $1.5B | $-29.9M | ||
| Q1 24 | $1.6B | $-31.7M |
总资产FBRTRIGL
| Q4 25 | $6.1B | $513.6M | ||
| Q3 25 | $6.2B | $242.5M | ||
| Q2 25 | $5.6B | $206.7M | ||
| Q1 25 | $5.7B | $176.0M | ||
| Q4 24 | $6.0B | $164.0M | ||
| Q3 24 | $6.3B | $139.4M | ||
| Q2 24 | $6.3B | $128.4M | ||
| Q1 24 | $6.0B | $126.5M |
负债/权益比FBRTRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $291.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 15.88× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FBRTRIGL
| Q4 25 | $291.9M | $22.0M | ||
| Q3 25 | $-148.1M | $24.0M | ||
| Q2 25 | $11.8M | $30.5M | ||
| Q1 25 | $116.2M | $-893.0K | ||
| Q4 24 | $57.2M | $14.5M | ||
| Q3 24 | $97.4M | $21.7M | ||
| Q2 24 | $1.9M | $302.0K | ||
| Q1 24 | $13.0M | $-5.0M |
现金转化率FBRTRIGL
| Q4 25 | 15.88× | 0.08× | ||
| Q3 25 | -8.56× | 0.86× | ||
| Q2 25 | 0.51× | 0.51× | ||
| Q1 25 | 4.83× | -0.08× | ||
| Q4 24 | 1.90× | 1.01× | ||
| Q3 24 | 3.08× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.36× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FBRT
| New Point Holdings JVLLC | $77.3M | 95% |
| Other | $2.1M | 3% |
| Office Building | $1.7M | 2% |
RIGL
暂无分部数据
